Pharming Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Pharming Group stock prices and determine the direction of Pharming Group NV's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Pharming Group's historical fundamentals, such as revenue growth or operating cash flow patterns.
Pharming
On December 4, 2024 Pharming Group NV had Accumulation Distribution of 86310.64. The accumulation distribution (A/D) indicator shows the degree to which Pharming Group is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Pharming Group NV to determine if accumulation or reduction is taking place in the market. This value is adjusted by Pharming Group trading volume to give more weight to distributions with higher volume over lower volume.
On December 05 2024 Pharming Group NV was traded for 0.72 at the closing time. The highest price during the trading period was 0.72 and the lowest recorded bid was listed for 0.71 . The volume for the day was 3.1 M. This history from December 5, 2024 did not cause price change. The trading delta at closing time to the current price is 5.56% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
For every potential investor in Pharming, whether a beginner or expert, Pharming Group's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pharming Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pharming. Basic forecasting techniques help filter out the noise by identifying Pharming Group's price trends.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharming Group stock to make a market-neutral strategy. Peer analysis of Pharming Group could also be used in its relative valuation, which is a method of valuing Pharming Group by comparing valuation metrics with similar companies.
Pharming Group NV Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Pharming Group's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Pharming Group's current price.
Market strength indicators help investors to evaluate how Pharming Group stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharming Group shares will generate the highest return on investment. By undertsting and applying Pharming Group stock market strength indicators, traders can identify Pharming Group NV entry and exit signals to maximize returns.
The analysis of Pharming Group's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pharming Group's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pharming stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Information and Resources on Investing in Pharming Stock
When determining whether Pharming Group NV is a strong investment it is important to analyze Pharming Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pharming Group's future performance. For an informed investment choice regarding Pharming Stock, refer to the following important reports:
Please note, there is a significant difference between Pharming Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharming Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharming Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.